TCL Archive In Brief: Lepovetsky Heads New NCI Office Of Technology Development; Temporary Now, Maybe Permanent November 27, 1987
TCL Archive Randomized Trial Finds Supplement Use Didn’t Prevent Prostate Cancer After 5 Years. October 31, 2008
TCL Archive Also NSABP’s STAR Trial Finds Raloxifene Equivalent To Tamoxifen For Breast Cancer Risk Reduction. April 21, 2006